Immuno- and antiinflammatory therapies in epileptic disorders

Epilepsia

Volumn 52, Issue SUPPL. 3, 2011, Pages 45-51

  Özkara, Çiǧdem ^a   Vigevano, Federico ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

ACTH; Epilepsy; Immunological therapies; IVIg; Plasmapheresis; Steroids

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOTROPIN; CYCLOPHOSPHAMIDE; DEFLAZACORT; GANAXOLONE; HYDROCORTISONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID;

ADRENAL SUPPRESSION; ALLERGIC REACTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BENIGN CHILDHOOD EPILEPSY; BRAIN ATROPHY; CUSHING SYNDROME; DRUG DOSE TITRATION; EPILEPSY; EPILEPTIC STATE; GLUCOSE INTOLERANCE; GROWTH RETARDATION; HASHIMOTO ENCEPHALOPATHY; HEADACHE; HUMAN; HYPERTENSION; IMMUNOTHERAPY; INFANTILE SPASM; INFECTION; IRRITABILITY; OSTEOPOROSIS; PLASMAPHERESIS; PRIORITY JOURNAL; SIDE EFFECT; SOMNOLENCE; STOMACH IRRITATION; VEIN THROMBOSIS; WEIGHT GAIN;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CLINICAL TRIALS AS TOPIC; EPILEPSY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; STEROIDS;

EID: 79955702777     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2011.03036.x     Document Type: Article

References (49)

1. Agrawal S, Vincent A, Jacobson L, Milford D, Gupta R, Wassmer E,. (2010) Successful treatment of anti-N-methyl-d-aspartate receptor limbic encephalitis in a 22-month old child with plasmapheresis and pharmacological immunomodulation. Arch Dis Child 95: 312.
2. Andrews PI, Dichter MA, Berkovic SF, Newton MR, McNamara JO,. (1996) Plasmapheresis in Rasmussen's encephalitis. Neurology 46: 242-246. (Pubitemid 26156139)
3. Antozzi C, Granata T, Aurisano N, Zardini G, Confalonieri P, Airaghi G, Mantegazza Spreafico R,. (1998) Long-term selective IgG immuno-adsorption improves Rasmussen's encephalitis. Neurology 51: 302-305. (Pubitemid 28345410)
4. Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen MH, Lassmann H, Mantegazza R, Villemure JG, Spreafico R, Elger CE,. (2005) Pathogenesis, diagnosis and treatment of Rasmussen encephalitis A European consensus statement. Brain 128: 454-471. (Pubitemid 40380182)
5. Brain L, Jellinek EH, Ball K,. (1966) Hashimoto's disease and encephalopathy. Lancet 288: 512-514.
6. Buzatu M, Bulteau C, Altuzarra C, Dulac O, van Bogaert P,. (2009) Corticosteroids as treatment of epileptic syndromes with continuous spike-waves during slow-wave sleep. Epilepsia 50 (suppl 7): S68-S72.
7. Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, Hunder G, Fatourechi V, Mokri B, Drubach D, Pittock S, Lennon V, Boeve B,. (2006) Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 63: 197-202. (Pubitemid 43261730)
8. Chaudhuri A, Behan PO,. (2003) The clinical spectrum, diagnosis, pathogenesis and treatment of Hashimoto's encephalopathy (recurrent acute disseminated encephalomyelitis). Curr Med Chem 10: 1945-1953. (Pubitemid 37139056)
9. Chiron C, Dulac O, Bulteau C, Nuttin C, Depas G, Raynaud C, Syrota A,. (1993) Study of regional cerebral blood flow in West syndrome. Epilepsia 34: 707-715. (Pubitemid 23228136)
10. Chiron C, Dumas C, Jeambaqué I, Mumford J, Dulac O,. (1997) Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 26: 389-395. (Pubitemid 27117815)
11. Chong JY, Rowland LP, Utiger RD,. (2003) Hashimoto encephalopathy: syndrome or myth? Arch Neurol 60: 164-171. (Pubitemid 36193958)
12. Dietrich G, Kaveri SV, Kazatchkine MD,. (1992) Modulation of autoimmunity by intravenous immune globulin trough interaction with the function of the immune/idiotypic network. Clin Immunol Immunopathol 62 (suppl): S73-S81.
13. Elovaara I, Apostolski S, van Doorn P, Gilhus NE, Hietaharju A, Honkaniemi J, van Schaik IN, Scolding N, Soelberg SÃrensen P, Udd B,. (2008) EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS Task Force on the Use of Intravenous Immunoglobulin in Treatment of Neurological Diseases. Eur J Neurol 15: 893-908.
14. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J,. (2009) Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66: 11-18.
15. Gayatri NA, Ferrie CD, Cross H,. (2007) Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms. Cochrane Database Syst Rev Issue 1: CD005222.
16. Gayatri N, Ferrie CD, Cross JH,. (2009) Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms (updated review). Cochrane Database Syst Rev Issue 1: CD005222.
17. Granata T, Fusco L, Gobbi G, Freri E, Ragona F, Broggi G, Mantegazza R, Giordano L, Villani F, Capovilla G, Vigevano F, Dalla Bernardina B, Spreafico R, Antozzi C,. (2003) Experience with immunomodulatory treatments in Rasmussen's encephalitis. Neurology 61: 1807-1810. (Pubitemid 38020838)
18. Grosso S, Farnetani M, Mostardini R, Cordelli D, Beradi R, Balestri P,. (2008) A comparative study of hydrocortisone versus deflazacort in drug-resistant epilepsy of childhood. Epilepsy Res 81: 80-85.
19. Hancock EC, Osborne JP, Edwards SW,. (2008) Treatment of infantile spasms. Cochrane Database Syst Rev Issue 3: CD001770.
20. Hussain NS, Rumbaugh J, Kerr D, Nath A, Hillis AE,. (2005) Effects of prednisone and plasma exchange on cognitive impairment in Hashimoto encephalopathy. Neurology 64: 165-166. (Pubitemid 40082963)
21. Illum N, Taudorf K, Heilmann C, Smith T, Wulff K, Mansa B, Platz P,. (1990) Intravenous immunoglobulin: a single blind trial in children with Lennox-Gastaut syndrome. Neuropediatrics 21: 87-89.
22. Irani SR, Buckley C, Vincent A, Cockerell OC, Rudge P, Johnson MR, Smith S,. (2008) Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 71: 1647-1648.
23. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A,. (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133: 1655-1667.
24. Kerrigan JF, Shields WD, Nelson TY, Bluestone DL, Dodson WE, Bourgeois BF, Pellock JM, Morton LD, Monaghan EP,. (2000) Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial. Epilepsy Res 42: 133-139.
25. Klein R, Livingston S,. (1950) The effect of adrenocorticotrophic hormones in epilepsy. J Pediatr 37: 733-742.
26. Laxer K, Blum D, Abou-Khalil BW, Morrell M, Lee DA, Data JL, Monaghan EP, for the Ganaxolone presurgical study group. (2000) Assessment of Ganaxolone's anticonvulsant activity using a randomised, double-blind, presurgical trial design. Epilepsia 41: 1187-1194.
27. Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP,. (2004) The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 364: 1773-1778. (Pubitemid 39488062)
28. Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP,. (2005) The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 4: 712-717. (Pubitemid 41457286)
29. Matà S, Muscas GC, Naldi I, Rosati E, Paladini S, Cruciatti B, Bisulli F, Paganini M, Mazzi G, Sorbi S, Tinuper P,. (2008) Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol 199: 155-159.
30. McQuarrie I, Anderson JA, Ziegler MR,. (1942) Observation on the antagonistic effects of posterior pituitary and cortical-adrenal hormones in the epileptic subject. J Clin Endocrinol 2: 406-410.
31. Mikati MA, Kurdi R, El-Khoury Z, Rahi A, Raad W,. (2010) Intravenous immunoglobulin therapy in intractable childhood epilepsy: open-label study and review of the literature. Epilepsy Behav 17: 90-94.
32. Nagpal T, Pande S,. (2004) Hashimoto's encephalopathy: response to plasma exchange. Neurol India 52: 245-247. (Pubitemid 39136964)
33. O'Regan ME, Brown JK,. (1998) Is ACTH a key to understanding anticonvulsant action? Dev Med Child Neurol 40:8289. Dev Med Child Neurol 40: 82-89.
34. Pechadre JC, Sauvezie B, Osier C, Gibert J,. (1977) Traitement des encephalopathies epileptiques de l'enfant pa les gammaglobulines. Rev Electroencephalogr Neurophysiol 7: 443-447. (Pubitemid 8292125)
35. Pentella K, Bachman DS, Sandman CA,. (1982) Trial of an ACTH4-9 Analogue (ORG 2766) in children with intractable seizures. Neuropediatrics 13: 59-62. (Pubitemid 12082433)
36. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B, Hughes TE, Heinemann SF, McNamara JO,. (1994) Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265: 648-651.
37. Schäuble B, Castillo PR, Boeve BF, Westmoreland BF,. (2003) EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clin Neurophysiol 114: 32-37. (Pubitemid 35454169)
38. Schimmel M, Bien CG, Vincent A, Schenk W, Penzien J,. (2009) Successful treatment of anti-N-methyl-d-aspartate receptor encephalitis presenting with catatonia. Arch Dis Child 94: 314-316.
39. Thilo B, Stingele R, Knudsen K, Boor R, Bien CG, Deuschl G, Lang N,. (2009) A case of Rasmussen encephalitis treated with rituximab. Nat Rev Neurol 5: 458-462.
40. van Engelen BG, Renier WO, Weemaes CM, Gabreels FJ, Meinardi H,. (1994) Immunoglobulin treatment in epilepsy, a review of the literature. Epilepsy Res 19: 181-190.
41. van Rijckevorsel-Harmant K, Delire M, Schmitz-Moorman W, Wieser HG,. (1994) Treatment of refractory epilepsy with intravenous immunoglobulins: results of the first double-blind/dose finding clinical study. Int J Clin Lab Res 24: 162-166.
42. Vezzani A, Granata T,. (2005) Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46: 1724-1743. (Pubitemid 44921957)
43. Vezzani A, French J, Bartfai T, Baram TZ,. (2011) The role of inflammation in epilepsy. Nat Rev Neurol 7: 31-40.
44. Vigevano F, Cilio MR,. (2009) Adrenocorticotropic hormone and corticosteroids. In, Shorvon S, Perucca E, Engel J, (Eds) The treatment of epilepsy, 3rd ed. Blackwell Publishing, Oxford, pp. 411-419.
45. Villani F, Avanzini G,. (2002) The use of immunoglobulins in the treatment of human epilepsy. Neurol Sci 23 (suppl): S33-S37. (Pubitemid 34568198)
46. Villani F, Bien CG, Avanzini G,. (2008) Immunoglobulin and immunomodulatory therapy. In, Engel J Jr, Pedley TA, (Eds) Epilepsy, a comprehensive textbook, 2nd ed. Lippincott Williams & Wilkins, Philadelphia, pp. 1741-1746.
47. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S, Lang B, Rossor MN, Palace J,. (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy- responsive form of limbic encephalitis. Brain 127: 701-712. (Pubitemid 38295483)
48. Vincent A, Irani SR, Lang B,. (2010) The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Curr Opin Neurol 23: 144-150.
49. Wong SH, Saunders MD, Larner AJ, Das K, Hart IK,. (2010) An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis. J Neurol Neurosurg Psychiatry 81: 1167-1169.